Belén Garijo: The only way we can succeed in accelerating the transition of the global healthcare industry to a net zero future is TOGETHER

Belén Garijo, shared a post by The Sustainable Markets Initiative on LinkedIn, adding:

“The only way we can succeed in accelerating the transition of the global healthcare industry to a net zero future is TOGETHER. Congratulations to all members of The Sustainable Markets Initiative Health Systems Taskforce for the great teamwork. Our momentum is inspiring many others to join us.”

Quoting The Sustainable Markets Initiative’s post:

“Ahead of COP28UAE, our Health Systems Task Force has shared the bold, sector-first action it is taking to accelerate the transition to net zero health systems. This includes progressing renewable power sourcing models in China and India and developing a framework to measure the environmental impact of medicines through public-private partnership. Learn more here.”

To watch the video, click here.
Source: Belén Garijo/LinkedIn and The Sustainable Markets Initiative/LinkedIn

Belén Garijo is the Chair of the Executive Board and CEO of Merck KGaA, Darmstadt, Germany. She joined the company in 2011 as Chief Operating Officer of the Biopharma business, becoming President and CEO of Healthcare in 2015. In July 2020, Belén Garijo was appointed Vice Chairman of the Executive Board and Deputy CEO in addition to her role as CEO of the Healthcare business. She moved from Deputy CEO to CEO in May 2021. Under her leadership, Healthcare at Merck KGaA, Darmstadt, Germany, has become a key player in the area of oncology, immunology and immuno-oncology, after the profound repositioning of the portfolio, the reorganization of R&D and the transformation of the commercial model. Before joining Merck, Belén Garijo served as the Senior Vice President of Global Operations Europe at Sanofi-Aventis and Global Integration Leader of Genzyme after its acquisition by Sanofi. She previously held several local and global executive positions, both in R&D and commercial, at various companies at the forefront of the Healthcare sector. She started her career as a practicing physician at La Paz hospital in Madrid before moving to the pharmaceutical industry. She is a medical doctor, specialized in clinical pharmacology.